v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Operating activities:      
Net income (loss) attributable to the Company $ (229,535) $ (5,138) $ 46,625
Adjustments to reconcile net income to net cash provided by (used for) operating activities:      
Depreciation and amortization 77,038 48,187 45,945
Deferred income taxes and related valuation allowance (10,711) (20,256) (15,285)
Net gain from sale of business (103,306) 0 0
Net loss (gain) on sale of real estate, investments and other (2,551) (972) (1,431)
Stock-based compensation 9,569 6,256 12,039
Amortization of deferred financing costs 3,549 2,487 2,349
Loss (gain) on hedging instruments 1,720 (382) (1,366)
Loss on impairment of goodwill 200,000 0 0
Cost of debt refinancing and repricing 24,185 0 958
Impairment of operating lease 0 3,911 0
Loss on disposals and impairments of fixed assets 0 2,533 0
Non-cash pension settlement expense (See Note 13) 0 23,634 4,984
Non-cash lease expense 9,978 10,105 9,735
Changes in operating assets and liabilities, net of effects of business acquisitions and divestitures:      
Trade accounts receivable (10,675) 4,482 (14,428)
Inventories 15,268 (13,042) (1,314)
Prepaid expenses and other 9,864 (20,998) (8,555)
Other assets 2,003 3,498 537
Trade accounts payable (2,646) 11,144 4,748
Accrued liabilities (129,800) (250) (9,583)
Non-current liabilities (10,161) (9,587) (8,760)
Net cash provided by (used for) operating activities (146,211) 45,612 67,198
Investing activities:      
Proceeds from sales of marketable securities 3,535 5,057 3,526
Purchases of marketable securities (3,174) (3,676) (4,076)
Capital expenditures (17,859) (21,411) (24,813)
Proceeds from sale of buildings, net of transaction costs 3,257 0 0
Dividend received from equity method investment 0 0 144
Proceeds from sale of fixed assets 0 139 0
Net proceeds from the sales of businesses 183,976 0
Purchase of businesses, net of cash and restricted cash acquired (See Note 3) (2,627,389) 0 (108,145)
Net cash provided by (used for) investing activities (2,457,654) (19,891) (133,364)
Financing activities:      
Proceeds from issuance of common stock 30 371 1,600
Proceeds from issuance of preferred stock, net of expenses 780,978 0 0
Fees paid for debt repricing 0 (169) (958)
Purchases of treasury stock 0 (10,000) 0
Repayment of debt (616,177) (60,670) (60,604)
Payment to former owners of montratec (see Note 3) 0 (6,711) 0
Fees paid for borrowing on long-term debt (91,004) 0 (2,859)
Proceeds from issuance of long-term debt 2,590,000 0 120,000
Cash inflows from hedging activities 23,165 23,608 24,057
Cash outflows from hedging activities (24,809) (23,134) (22,687)
Payment of dividends (8,037) (8,042) (8,044)
Other (732) (2,000) (2,304)
Net cash provided by (used for) financing activities 2,653,414 (86,747) 48,201
Effect of exchange rate changes on cash (6,459) 583 (1,085)
Net change in cash and cash equivalents 43,090 (60,443) (19,050)
Cash, cash equivalents, and restricted cash at beginning of year 53,933 114,376 133,426
Cash, cash equivalents, and restricted cash at end of year 97,023 53,933 114,376
Supplementary cash flows data:      
Interest paid 45,630 30,054 34,983
Income taxes paid, net of refunds 45,850 20,520 28,369
Property, plant and equipment purchases included in trade accounts payable 2,398 318 690
Restricted cash presented in Other assets $ 461 $ 250 $ 250